BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24111)

  • 1. Effects of bromocriptine on adenylate cyclase and phosphodiesterase activities of rat striatum.
    Pagnini G; Camanni F; Crispino A; Portaleone P
    J Pharm Pharmacol; 1978 Feb; 30(2):92-5. PubMed ID: 24111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine and hydergine: a comparison on striatal or hypothalamic adenylate cyclase activity.
    Portaleone P
    Pharmacology; 1978; 16 Suppl 1():207-9. PubMed ID: 643903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum.
    Puri SK; Cochin J; Volicer L
    Life Sci; 1975 Mar; 16(5):759-67. PubMed ID: 164598
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine-sensitive adenylate cyclase and cAMP phosphodiesterase in substantia nigra and corpus striatum of rat brain.
    Traficante LJ; Friedman E; Oleshansky MA; Gershon S
    Life Sci; 1976 Oct; 19(7):1061-6. PubMed ID: 186677
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism.
    Markstein R; Herrling PL
    J Neurochem; 1978 Nov; 31(5):1163-72. PubMed ID: 702165
    [No Abstract]   [Full Text] [Related]  

  • 6. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
    Quik M; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum.
    Puri SK; Volicer L
    Mech Ageing Dev; 1977; 6(1):53-8. PubMed ID: 189140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct interactions between Ca2+/calmodulin and neurotransmitter stimulation of adenylate cyclase in striatum and hippocampus.
    Ahlijanian MK; Cooper DM
    Cell Mol Neurobiol; 1988 Dec; 8(4):459-69. PubMed ID: 3224361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oxiferriscorbone on striatal adenylate cyclase of the rat.
    Moser A; Schuster O
    Neuropharmacology; 1990 Aug; 29(8):731-4. PubMed ID: 2274108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfated cholecystokinin octapeptide (CCK8) failed to modulate basal or dopamine-stimulated adenylate cyclase activity in the rat striatum.
    Morency MA; Ross GM; Kajiura JS; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):331-6. PubMed ID: 3387592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drugs stimulating dopaminergic system on phosphodiesterase activity in rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1976; 28(6):631-4. PubMed ID: 189292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
    Thomas TN; Zemp JW
    J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmortem stability of dopamine-sensitive adenylate cyclase, guanylate cyclase, ATPase, and GTPase in rat striatum.
    Nicol SE; Senogles SE; Caruso TP; Hudziak JJ; McSwigan JD; Frey WH
    J Neurochem; 1981 Dec; 37(6):1535-9. PubMed ID: 6120996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of adenylate cyclase in rat striatum by pergolide: influence of GTP.
    Rosenfeld MR; Makman MH; Goldstein M
    Eur J Pharmacol; 1980 Nov; 68(1):65-8. PubMed ID: 7449835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.
    Nakahara T; Uchimura H; Saito M; Hirano M; Kim JS; Ito M
    J Neurochem; 1978 Nov; 31(5):1335-7. PubMed ID: 702178
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of the dopamine-sensitive adenylate cyclase in the striatum and hypothalamus of rat brain.
    Roufogalis BD; Thornton M; Wade DN
    J Pharm Pharmacol; 1979 Jan; 31(1):33-8. PubMed ID: 32363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors.
    Bockaert J; Premont J; Glowinski J; Thierry AM; Tassin JP
    Brain Res; 1976 May; 107(2):301-15. PubMed ID: 1268730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.